NTLA
Intellia Therapeutics
Rating 3.2 / 5 AI signal Hold signal

Credit put spread analysis · · Moderate setup

IV Rank
29
Implied volatility percentile
Trend
0.67
Long-term trend score
Safety
4/10
Quality checks passed
Drop
-7.6%
Day 5 of drop
1Y Change
33.3%
Trailing 12 months
Earnings
Clear
No event in window

AI analysis

[dedup-flagged] Here's the risk/reward in plain English: This 7. 5% drop is a blip in a stock that's still up 33% in two months, with realized volatility screaming at 88%. IV at 29% is actually cheap relative to that, so the premium pays.

The chart shows no reversal signal, but that's the risk—this is a biotech pinball machine. Support around $14. 50 is the real floor; a break there and the trade is toast.

Structure-wise, selling a put just below that level and buying a cheaper one defines the risk cleanly. The credit-to-width ratio works, but size small—this isn't a sleep-easy trade. A decent setup if you respect the wild ride.

Earlier analyses

  1. 3.2/5 Hold signal

    The premium math is where this gets interesting: IV at 30% looks cheap against 86% realized vol, but that's a red flag. The stock's up 21% in two months, then gets cut by a third of that in one day — that's not a healthy…